Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17

Completed · Phase 4

Conditions studied: Rheumatic Diseases

In brief

Participants diagnosed as having fibromyalgia, osteoarthritis, and rheumatoid arthritis are to be brought to a minimum symptom state using a 3-week period during which they are to ingest modest doses of cortisol tablets with weekly lowered tapered doses. Thereafter, the participants are to be taught to self-administer cortisol tablets on the as-needed basis to maintain the minimum symptom state. For this, they are to ingest a smaller-dosage, 5-day tapered regimen of cortisol tablets to quench each reoccurring exacerbation of the disease at its earliest stage. Participants are limited to using less than the safe use limit of cortisol per month and are required to include a minimum of 10 days per month during which no cortisol was ingested.

Key facts

Study ID

NCT03558971

Run by

Helen Foundation

People needed

2430

Starts

2000-01-01

Expected to finish

2016-12-31

Last updated by the study team

2018-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnoses of fibromyalgia, osteoarthritis, or rheumatoid arthritis -

You may not qualify if…

• Congestive heart failure, stomach ulceration, unstable diabetes, and bipolar disorder

Where it is running

• Helen Foundation Clinic — Apache Junction, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.